Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

AIM OF THE STUDY: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Fermér, Christian, Nilsson, Olle, Seppänen, Hanna, Haglund, Caj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459962/
https://www.ncbi.nlm.nih.gov/pubmed/26053486
http://dx.doi.org/10.1371/journal.pone.0129012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459962/
https://www.ncbi.nlm.nih.gov/pubmed/26053486
http://dx.doi.org/10.1371/journal.pone.0129012

Ejemplares similares